{
    "ticker": "COLL",
    "name": "Collegium Pharmaceutical, Inc.",
    "description": "Collegium Pharmaceutical, Inc. is a specialty pharmaceutical company focused on the development and commercialization of innovative products that treat chronic pain and other medical conditions. Founded in 2008 and headquartered in Stoughton, Massachusetts, Collegium aims to improve the lives of patients by providing effective and safe therapies, primarily through its lead product, Xtampza ER, an abuse-deterrent formulation of oxycodone. The company is committed to addressing the opioid crisis by developing formulations that minimize the risk of misuse while effectively managing pain. Collegium is also engaged in the development of new therapies and formulations that leverage its advanced drug delivery technologies, expanding its product pipeline with additional candidates aimed at treating various pain-related conditions and other therapeutic areas. The company's mission is to provide innovative solutions that enhance patient care and reduce the burden of chronic pain, while also prioritizing safety and efficacy in its product offerings.",
    "industry": [
        "Pharmaceuticals",
        "Biotechnology"
    ],
    "headquarters": "Stoughton, Massachusetts, USA",
    "founded": "2008",
    "website": "https://www.collegiumpharma.com",
    "ceo": "Joe C. M. DeVita",
    "social_media": {
        "twitter": "https://twitter.com/CollegiumPharma",
        "linkedin": "https://www.linkedin.com/company/collegium-pharmaceutical/"
    },
    "investor_relations": "https://investors.collegiumpharma.com",
    "key_executives": [
        {
            "name": "Joe C. M. DeVita",
            "position": "CEO"
        },
        {
            "name": "Michael A. Heffernan",
            "position": "President"
        },
        {
            "name": "Sophie J. M. Lee",
            "position": "CFO"
        }
    ],
    "product_categories": [
        {
            "category": "Chronic Pain Management",
            "products": [
                "Xtampza ER",
                "Pillars of Pain Management"
            ]
        }
    ],
    "seo": {
        "meta_title": "Collegium Pharmaceutical, Inc. | Innovative Pain Management Solutions",
        "meta_description": "Discover Collegium Pharmaceutical, Inc., a leader in chronic pain management solutions. Learn about their innovative products and commitment to patient care.",
        "keywords": [
            "Collegium Pharmaceutical",
            "Chronic Pain",
            "Oxycodone",
            "Xtampza ER",
            "Abuse-Deterrent",
            "Pharmaceuticals"
        ]
    },
    "faq": [
        {
            "question": "What is Collegium Pharmaceutical known for?",
            "answer": "Collegium Pharmaceutical is known for its innovative chronic pain management solutions, particularly its lead product, Xtampza ER."
        },
        {
            "question": "Who is the CEO of Collegium Pharmaceutical?",
            "answer": "Joe C. M. DeVita is the CEO of Collegium Pharmaceutical, Inc."
        },
        {
            "question": "Where is Collegium Pharmaceutical headquartered?",
            "answer": "Collegium Pharmaceutical is headquartered in Stoughton, Massachusetts, USA."
        },
        {
            "question": "What are Collegium's main products?",
            "answer": "Collegium's main products include Xtampza ER and various pain management initiatives."
        },
        {
            "question": "When was Collegium Pharmaceutical founded?",
            "answer": "Collegium Pharmaceutical was founded in 2008."
        }
    ],
    "competitors": [
        "PTGX",
        "ACAD",
        "PFE",
        "AMRX"
    ],
    "related_stocks": [
        "JNJ",
        "ABBV",
        "MRK",
        "BMY"
    ]
}